Patents by Inventor Mathias SCHUETZ

Mathias SCHUETZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PRODUCTION OF GLYCOSYLATED CANNABINOIDS
    Publication number: 20230340555
    Abstract: The present disclosure provides methods for making glycosylated cannabinoids including methods using recombinant host cells comprising a pathway capable of producing a cannabinoid and a heterologous nucleic acid that encodes a UDP-glycosyl transferase. The disclosure also provides compositions of recombinant host cells capable of producing glycosylated cannabinoids, and compositions and uses of the glycosylated cannabinoids.
    Type: Application
    Filed: May 3, 2023
    Publication date: October 26, 2023
    Applicants: WILLOW BIOSCIENCES, INC., EPIMERON USA, INC.
    Inventors: Mathias Schuetz, Gisele Passaia Prietsch
  • Compositions and Methods for Recombinant Biosynthesis of Cannabinoids
    Publication number: 20230193329
    Abstract: The present disclosure provides recombinant host cells comprising a pathway capable of producing a cannabinoid and a nucleic acid derived from a Cannabis trichome mRNA that that does not encode an enzyme in the pathway but enhances the host cells' ability to produce the cannabinoid. The disclosure also provides methods of using host cells to produce cannabinoids.
    Type: Application
    Filed: September 26, 2022
    Publication date: June 22, 2023
    Applicant: Willow Biosciences, Inc.
    Inventor: Mathias Schuetz
  • RECOMBINANT ACYL ACTIVATING ENZYME (AAE) GENES FOR ENHANCED BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS
    Publication number: 20220186231
    Abstract: The present disclosure provides recombinant host cells comprising a pathway capable of producing a cannabinoid and/or cannabinoid precursor, wherein the pathway comprises an enzyme AAE from a source organism other than Cannabis sativa, such as Humulus lupulus. The disclosure also provides methods of using the host cells to produce rare cannabinoids and/or rare cannabinoid precursors.
    Type: Application
    Filed: December 10, 2021
    Publication date: June 16, 2022
    Applicants: Willow Biosciences, Inc., Epimeron USA, Inc.
    Inventors: Mathias SCHUETZ, Michal PYC